During the past decade, Jinhua Central Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.8% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 1 clinical trials were completed. i.e. 5.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jinhua Central Hospital" #1 sponsor was "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 6 trials, followed by "Jinhua Central Hospital" with 5 trials sponsored, "BeiGene" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Beijing InnoCare Pharma Tech Co., Ltd." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jinhua Central Hospital" #1 collaborator was "Jinhua Municipal Central Hospital" with 2 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator, "Beijing Shijitan Hospital, Capital Medical University" with 1 trials as a collaborator, "Children's Hospital of Fudan University" with 1 trials as a collaborator and "First Affiliated Hospital of Wenzhou Medical University" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Jinhua Central Hospital" are "Nasopharyngeal Carcinoma" (2 trials), "Rheumatoid Arthritis" (2 trials), "Acute Kidney Injury" (1 trials), "COPD Patients" (1 trials) and "Chronic Kidney Diseases" (1 trials). Many other conditions were trialed in "Jinhua Central Hospital" in a lesser frequency.

Most popular intervention types in "Jinhua Central Hospital" are "Drug" (13 trials), "Dietary Supplement" (3 trials), "Biological" (2 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Tislelizumab" (2 trials), "3 cycles of Neoadjuvant Chemotherapy With concurrent chemoradiotherapy" (1 trials), "4 cycles of Neoadjuvant Chemotherapy With Definitive Radiotherapy" (1 trials) and "CEMR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jinhua Central Hospital" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Jinhua Central Hospital". undefined are not yet recruiting, 12 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Jinhua Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jinhua Central Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".